Details for Patent: 4,406,906

Summary for Patent: 4,406,906

Title:	Cerebral therapeutic agent and its use
Abstract:	The invention provides pharmaceutical compositions and medicaments, useful for the treatment of cerebral disorders, wherein the active compound is 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3-(.beta.-methoxyethy l ester)-5-(isopropyl ester). Also included in the invention are methods for the use of said compositions and medicaments.
Inventor(s):	Meyer; Horst (Wuppertal, DE), Bossert; Friedrich (Wuppertal, DE), Kazda; Stanislav (Wuppertal, DE), Hoffmeister; Friedrich (Wuppertal, DE), Vater; Wulf (Leverkusen, DE)
Assignee:	Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:	06/346,319
Patent Claim Types: see list of patent claims	Use; Delivery;

Drugs Protected by US Patent 4,406,906

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,406,906

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	2815578	Apr 11, 1978

International Family Members for US Patent 4,406,906

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	383271
Austria	A262179
Australia	4583579
Australia	532623
Belgium	875457
Canada	1140853
Switzerland	640734